Nektar Therapeutics
NKTR
NKTR
358 hedge funds and large institutions have $16.7B invested in Nektar Therapeutics in 2018 Q1 according to their latest regulatory filings, with 127 funds opening new positions, 89 increasing their positions, 124 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
358
Holders Change
+93
Holders Change %
+35.09%
% of All Funds
8.22%
Holding in Top 10
18
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+28.57%
% of All Funds
0.41%
New
127
Increased
89
Reduced
124
Closed
32
Calls
$355M
Puts
$168M
Net Calls
+$187M
Net Calls Change
+$35.9M
Top Buyers
Top Sellers
1 |
BlackRock
New York
|
-$740M |
2 |
O
OppenheimerFunds
New York
|
-$413M |
3 |
PC
PointState Capital
New York
|
-$351M |
4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$197M |
5 |
Primecap Management
Pasadena,
California
|
-$138M |